For liraglutide (Figures 3S and 4S), substantially increased incidence risks of pancreatitis, acute nephritis, thyroid cancer, thyroid dysfunction, and leukemia were observed in comparison to both insulin and metformin groups. The gene discussed is INS; the disease is pancreatitis.